{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:14:35Z","timestamp":1788495275655,"version":"build-2803163510"},"reference-count":39,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004493","name":"International Atomic Energy Agency","doi-asserted-by":"publisher","award":["CRP E35010"],"award-info":[{"award-number":["CRP E35010"]}],"id":[{"id":"10.13039\/501100004493","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Background: Up to 95% of irradiated patients suffer from ionizing radiation (IR) induced early skin reaction, acute radiation dermatitis (ARD). Some experts think that additional skin hydration can reduce acute skin reactions. Individual radiosensitivity (IRS) determined from lymphocytes may help to predict acute radiation toxicity. The purpose of this study is to evaluate the clinical manifestation of ARD in different skincare groups during whole breast radiotherapy depending on IRS and other risk factors. Methods: A total of 108 early-stage breast cancer patients were randomized into best supportive care (BSC) and additional skincare (ASC) groups. IRS was evaluated using a G2 assay modified with caffeine-induced G2 checkpoint arrest. All patients received a 50 Gy dose to the breast planning target volume (PTV). Clinical assessment of ARD symptoms according to the CTCAE grading scale was performed once a week. Results: IRS was successfully determined for 91 out of 108 patients. A total of 10 patients (11%) had normal IRS, 47 patients (52%) were categorized as radiosensitive, and 34 (37%) as highly radiosensitive. There was no significant difference in the manifestation of ARD between patient groups by skincare or IRS. According to logistic regression, patients with bigger breasts were prone to more severe ARD (p = 0.002). Conclusions: The additional skincare did not improve skin condition during RT. A total of 89% of patients had increased radiosensitivity. IRS determined before RT did not show the predictive value for the manifestation of ARD. Logistic regression revealed that breast volume was the most significant risk factor for the manifestation of ARD.<\/jats:p>","DOI":"10.3390\/life12010020","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T10:16:18Z","timestamp":1640254578000},"page":"20","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Individual Radiosensitivity as a Risk Factor for the Radiation-Induced Acute Radiodermatitis"],"prefix":"10.3390","volume":"12","author":[{"given":"Juras","family":"Ki\u0161onas","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Institute, LT-08660 Vilnius, Lithuania"},{"name":"Department of Neurobiology and Biophysics, Vilnius University, LT-10257 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Venius","sequence":"additional","affiliation":[{"name":"Medical Physics Department, National Cancer Institute, LT-08660 Vilnius, Lithuania"},{"name":"Biomedical Physics Laboratory, National Cancer Institute, LT-08660 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Sevriukova","sequence":"additional","affiliation":[{"name":"Radiation Protection Centre, LT-08352 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindaugas","family":"Grybauskas","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Institute, LT-08660 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiva","family":"Dabkevi\u010dien\u0117","sequence":"additional","affiliation":[{"name":"Biobank, National Cancer Institute, LT-08660 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvydas","family":"Burneckis","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Institute, LT-08660 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0825-4884","authenticated-orcid":false,"given":"Ri\u010dardas","family":"Rotomskis","sequence":"additional","affiliation":[{"name":"Biomedical Physics Laboratory, National Cancer Institute, LT-08660 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"ref_1","unstructured":"(2021, December 19). International Agency for Research on Cancer. Estimated Number of Incident Cases and Deaths Worldwide, Females, All Ages. Available online: https:\/\/gco.iarc.fr\/today\/online-analysis-multi-bars?v=2020&mode=cancer&mode_population=countries&population=900&populations=900&key=total&sex=2&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=10&group_cancer=1&include_nmsc=1&include_nmsc_other=1&type_multiple=%257B%2522inc%2522%253Atrue%252C%2522mort%2522%253Atrue%252C%2522prev%2522%253Afalse%257D&orientation=horizontal&type_sort=0&type_nb_items=%257B%2522top%2522%253Atrue%252C%2522bottom%2522%253Afalse%257D&population_group_globocan_id=."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3747\/co.26.5225","article-title":"Recurrence and Mortality after Breast-Conserving Surgery without Radiation","volume":"26","author":"Guidolin","year":"2019","journal-title":"Curr. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0936-6555(05)80657-0","article-title":"Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: A prospective study of treatment practice at the Royal Marsden Hospital","volume":"8","author":"Fernando","year":"1996","journal-title":"Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.soncn.2011.02.009","article-title":"Evidence-Based Skin Care Management in Radiation Therapy: Clinical Update","volume":"27","author":"McQuestion","year":"2011","journal-title":"Semin. Oncol. Nurs."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0167-8140(99)00158-9","article-title":"Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer","volume":"55","author":"Barber","year":"2000","journal-title":"Radiother. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijrobp.2008.01.007","article-title":"Individual Radiosensitivity Measured with Lymphocytes May Predict the Risk of Acute Reaction After Radiotherapy","volume":"71","author":"Borgmann","year":"2008","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1748-717X-6-32","article-title":"Chromosomal radiosensitivity and acute radiation side effects after radiotherapy in tumour patients\u2014A follow-up study","volume":"6","author":"Braselmann","year":"2011","journal-title":"Radiat. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Palumbo, E., Piotto, C., Calura, E., Fasanaro, E., Groff, E., Busato, F., El Khouzai, B., Rigo, M., Baggio, L., and Romualdi, C. (2019). Individual Radiosensitivity in Oncological Patients: Linking Adverse Normal Tissue Reactions and Genetic Features. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00987"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5114\/jcb.2012.32556","article-title":"Clinical Investigations Comparative analysis of three functional predictive assays in lymphocytes of patients with breast and gynaecological cancer treated by radiotherapy","volume":"4","author":"Padjas","year":"2012","journal-title":"J. Contemp. Brachyther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaad.2019.02.047","article-title":"Management of acute radiation dermatitis: A review of the literature and proposal for treatment algorithm","volume":"81","author":"Rosenthal","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3747\/co.v17i4.493","article-title":"Prophylaxis and Management of Acute Radiation-Induced Skin Reactions: A Systematic Review of the Literature","volume":"17","author":"Salvo","year":"2010","journal-title":"Curr. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00520-012-1622-5","article-title":"Topical agent therapy for prevention and treatment of radiodermatitis: A meta-analysis","volume":"21","author":"Zhang","year":"2012","journal-title":"Support. Care Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00520-006-0063-4","article-title":"The prevention and management of acute skin reactions related to radiation therapy: A systematic review and practice guideline","volume":"14","author":"Bolderston","year":"2006","journal-title":"Support. Care Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/jid.2011.411","article-title":"Ionizing Radiation: The Good, the Bad, and the Ugly","volume":"132","author":"Ryan","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.6004\/jnccn.2017.0044","article-title":"NCCN Guidelines (R) Insights Breast Cancer, Version 1.2017 Featured Updates to the NCCN Guidelines","volume":"15","author":"Gradishar","year":"2017","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_17","unstructured":"Julia White, A.T., Arthur, D., Buchholz, T., MacDonald, S., Marks, L., Pierce, L., Recht, A., Rabinovitch, R., Taghian, A., and Vicini, F. (2021, December 19). Breast Cancer Atlas for Radiation Therapy Planning: Consensus Definitions. Available online: https:\/\/www.nrgoncology.org\/Portals\/0\/Scientific%20Program\/CIRO\/Atlases\/BreastCancerAtlas_corr.pdf?ver=2018-04-18-144201-270."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5200\/sm-hs.2016.073","article-title":"Micronuclei and G2 Assays for Assessment of Chromosomal Radiosensitivity as Assistant Tool in Radiotherapy: Method-Comparison Study","volume":"26","author":"Sevriukova","year":"2016","journal-title":"Sveik. Moksl."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.radonc.2011.09.021","article-title":"A standardized G2-assay for the prediction of individual radiosensitivity","volume":"101","author":"Pantelias","year":"2011","journal-title":"Radiother. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/09553000500147642","article-title":"Elevated G2 chromosomal radiosensitivity in Irish breast cancer patients: A comparison with other studies","volume":"81","author":"Howe","year":"2005","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1269\/jrr.10052","article-title":"G0 and G2 Chromosomal Assays in the Evaluation of Radiosensitivity in a Cohort of Italian Breast Cancer Patients","volume":"51","author":"Poggioli","year":"2010","journal-title":"J. Radiat. Res."},{"key":"ref_22","first-page":"121","article-title":"Chromosomal radiosensitivity in Ukrainian breast cancer patients and healthy individuals","volume":"34","author":"Ryabchenko","year":"2012","journal-title":"Exp. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1897-4287-11-12","article-title":"Hereditary breast cancer: Ever more pieces to the polygenic puzzle","volume":"11","author":"Bogdanova","year":"2013","journal-title":"Hered. Cancer Clin. Pr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2041-9414-1-9","article-title":"Low levels of ATM in breast cancer patients with clinical radiosensitivity","volume":"1","author":"Fang","year":"2010","journal-title":"Genome Integr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3747\/co.25.3707","article-title":"Ataxia\u2013Telangiectasia Gene (ATM) Mutation Heterozygosity in Breast Cancer: A Narrative Review","volume":"25","author":"Jerzak","year":"2018","journal-title":"Curr. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2478\/raon-2013-0061","article-title":"Individual radiosensitivity in a breast cancer collective is changed with the patients\u2019 age","volume":"48","author":"Auer","year":"2014","journal-title":"Radiol. Oncol."},{"key":"ref_27","first-page":"347","article-title":"Chromosomal radiosensitivity in breast cancer patients: Influence of age of onset of the disease","volume":"13","author":"Baeyens","year":"2005","journal-title":"Oncol. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1748-717X-7-217","article-title":"Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS)","volume":"7","author":"Sfintizky","year":"2012","journal-title":"Radiat. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radi.2019.12.006","article-title":"An audit of radiation-induced skin reactions in the inframammary fold; does breast size impact on the severity of the reaction?","volume":"26","author":"Southworth","year":"2020","journal-title":"Radiography"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11604-012-0073-8","article-title":"Assessment of radiation dermatitis using objective analysis for patients with breast cancer treated with breast-conserving therapy: Influence of body weight","volume":"30","author":"Yamazaki","year":"2012","journal-title":"Jpn. J. Radiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.2307\/3578758","article-title":"Intrinsic radiosensitivity and chromosome aberration analysis using fluorescence in situ hybridization in cells of two human tumor cell lines","volume":"138","author":"Lambin","year":"1994","journal-title":"Radiat. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0360-3016(00)01471-1","article-title":"Low-dose hypersensitivity: Current status and possible mechanisms","volume":"49","author":"Joiner","year":"2001","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Deneuve, S., Mirjolet, C., Bastogne, T., Duclos, M., Retif, P., Zrounba, P., Roux, P.-E., Poupart, M., Vogin, G., and Foray, N. (2021). Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity. Cancers, 13.","DOI":"10.3390\/cancers13102477"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Devic, C., Ferlazzo, M.L., Berthel, E., and Foray, N. (2020). Influence of Individual Radiosensitivity on the Hormesis Phenomenon: Toward a Mechanistic Explanation Based on the Nucleoshuttling of ATM Protein. Dose-Response, 18.","DOI":"10.1177\/1559325820913784"},{"key":"ref_35","first-page":"48","article-title":"Effect of radiotherapy-induced alteration of individual radiosensitivity on development of side effect in cancer patients","volume":"30","author":"Sevriukova","year":"2020","journal-title":"Health Sci. East. Eur."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.suronc.2015.06.005","article-title":"Systematic review and meta-analysis comparing hypofractionated with conventional fraction radiotherapy in treatment of early breast cancer","volume":"24","author":"Zhou","year":"2015","journal-title":"Surg. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10549-017-4118-7","article-title":"Hypofractionated whole breast radiotherapy in breast conservation for early-stage breast cancer: A systematic review and meta-analysis of randomized trials","volume":"162","author":"Valle","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","article-title":"Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement","volume":"7","author":"Correa","year":"2017","journal-title":"Pr. Radiat. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1245\/s10434-017-6130-x","article-title":"Meta-Analysis of Local Invasive Breast Cancer Recurrence after Electron Intraoperative Radiotherapy","volume":"25","author":"Harness","year":"2017","journal-title":"Ann. Surg. Oncol."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/1\/20\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:52:23Z","timestamp":1760169143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/1\/20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["life12010020"],"URL":"https:\/\/doi.org\/10.3390\/life12010020","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,23]]}}}